Inclusion Criteria : 
  -  Grade IV Glioblastoma , receiving chemotherapy with or without TTfields . 
  -  Progressive or recurrent disease requiring second line treatment
  -  evidence of progression of disease by brain MRI and are planned to receive chemotherapy
Exclusion Criteria : 
  -  Current use of another beta blocker that cannot be switched to carvedilol at the onset of the trial . 
  -  Systolic blood pressure <  90 mmHg and / or heart rate <  60 bpm without hypertensive medications
  -  Allergy to beta blockers
  -  Severe or uncontrolled asthma or COPD ( chronic obstructive pulmonary disease ) 